Search research articles
Contact Us
Filters
Showing results (101-110 of 167) with videos related to
Page
of 17
Sort By:
JCO Precision Oncology
|
September 3, 2021
Retrospective Case Series Analysis of <i>RAF</i> Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard Therapies
Andrew Hendifar, Edik M Blais, Brian Wolpin, et al.
The Journal of Experimental Medicine
|
April 6, 2016
Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer
Lucia D'Amico, Sahil Mahajan, Aude-Hélène Capietto, et al.
Cancer Medicine
|
May 2, 2022
A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond
Marcus S Noel, Semmie Kim, Marion L Hartley, et al.
Immunotherapy
|
February 27, 2025
ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis
Emma Guttman-Yassky, Eric Simpson, Robert Bissonnette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2023
Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration
Gregory L Beatty, Devora Delman, Jiayi Yu, et al.
American Journal of Clinical Oncology
|
July 2, 2015
Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Shahed N Badiyan, Jeffrey R Olsen, Andrew Y Lee, et al.
Plos One
|
September 19, 2014
Thymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction cancers
Laura W Goff, Nilay Thakkar, Liping Du, et al.
Plos One
|
October 17, 2013
Synergistic effects of concurrent blockade of PI3K and MEK pathways in pancreatic cancer preclinical models
Hua Zhong, Cesar Sanchez, Dirk Spitzer, et al.
Cancer Immunology, Immunotherapy : CII
|
March 22, 2014
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer
Roheena Z Panni, Dominic E Sanford, Brian A Belt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2018
Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin
Richard A Hubner, Antonio Cubillo, Jean-Frédéric Blanc, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 167) with videos related to
Sort By:
Page
of 17
JCO Precision Oncology
|
September 3, 2021
Retrospective Case Series Analysis of <i>RAF</i> Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard Therapies
Andrew Hendifar, Edik M Blais, Brian Wolpin, et al.
The Journal of Experimental Medicine
|
April 6, 2016
Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer
Lucia D'Amico, Sahil Mahajan, Aude-Hélène Capietto, et al.
Cancer Medicine
|
May 2, 2022
A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond
Marcus S Noel, Semmie Kim, Marion L Hartley, et al.
Immunotherapy
|
February 27, 2025
ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis
Emma Guttman-Yassky, Eric Simpson, Robert Bissonnette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2023
Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration
Gregory L Beatty, Devora Delman, Jiayi Yu, et al.
American Journal of Clinical Oncology
|
July 2, 2015
Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Shahed N Badiyan, Jeffrey R Olsen, Andrew Y Lee, et al.
Plos One
|
September 19, 2014
Thymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction cancers
Laura W Goff, Nilay Thakkar, Liping Du, et al.
Plos One
|
October 17, 2013
Synergistic effects of concurrent blockade of PI3K and MEK pathways in pancreatic cancer preclinical models
Hua Zhong, Cesar Sanchez, Dirk Spitzer, et al.
Cancer Immunology, Immunotherapy : CII
|
March 22, 2014
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer
Roheena Z Panni, Dominic E Sanford, Brian A Belt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2018
Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin
Richard A Hubner, Antonio Cubillo, Jean-Frédéric Blanc, et al.
Page
of 17